These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 17205459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
    Sukasem C, Churdboonchart V, Sirisidthi K, Riengrojpitak S, Chasombat S, Watitpun C, Piroj W, Tiensuwan M, Chantratita W.
    Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.
    Stone DR, Corcoran C, Wurcel A, McGovern B, Quirk J, Brewer A, Sutton L, D'Aquila RT.
    Clin Infect Dis; 2002 Oct 01; 35(7):883-6. PubMed ID: 12228827
    [Abstract] [Full Text] [Related]

  • 4. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.
    Dtsch Med Wochenschr; 2007 May 04; 132(18):977-82. PubMed ID: 17457780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Resistance and replication capacity assays: clinical utility and interpretation.
    Haubrich RH.
    Top HIV Med; 2004 May 04; 12(2):52-6. PubMed ID: 15184711
    [Abstract] [Full Text] [Related]

  • 7. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
    Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, Koulla-Shiro S, Mpoudi-Ngole E, Peeters M, Delaporte E.
    Clin Infect Dis; 2009 May 01; 48(9):1318-22. PubMed ID: 19320592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S, Zazzi M, Corsi P, Gonnelli A, Di Pietro M, Giacometti A, Almi P, Trezzi M, Boeri E, Gianotti N, Menzo S, Del Gobbo R, Francisci D, Nerli A, Galli L, De Luca A, Antiretroviral Resistance Cohort Analysis Study Group.
    Antivir Ther; 2009 May 01; 14(3):359-69. PubMed ID: 19474470
    [Abstract] [Full Text] [Related]

  • 10. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W, Gallardo AM, Galaz J, Afani A, Cortés E.
    Rev Med Chil; 2007 Nov 01; 135(11):1406-13. PubMed ID: 18259651
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].
    Rodriguez-Escudero MJ, Prada de Medio E, Rosa Herranz C, Martinez Medina MC, Franquelo Gutierrez R.
    Rev Esp Quimioter; 2007 Jun 01; 20(2):203-5. PubMed ID: 17893756
    [Abstract] [Full Text] [Related]

  • 14. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
    Llibre JM, Domingo P, del Pozo MA, Miralles C, Galindo MJ, Viciana I, Moreno S, Schapiro JM, Clotet B.
    J Antimicrob Chemother; 2008 Jan 01; 61(1):206-9. PubMed ID: 17999972
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S.
    J Med Virol; 2007 Sep 01; 79(9):1261-9. PubMed ID: 17607781
    [Abstract] [Full Text] [Related]

  • 17. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG, Boldrin C, Cruciani M, Nicolini G, Cerbaro I, Manfrin V, Dal Bello F, Franchin E, Franzetti M, Rossi MC, Cattelan AM, Romano L, Zazzi M, Andreoni M, Palù G.
    J Clin Microbiol; 2007 Jun 01; 45(6):1783-8. PubMed ID: 17442799
    [Abstract] [Full Text] [Related]

  • 18. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J, Brooks JT, Baker R, Hoffman M, Moorman A, Novak R, HOPS Investigators.
    Antivir Ther; 2007 Jun 01; 12(6):957-62. PubMed ID: 17926650
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.
    Eron JJ.
    J Infect Dis; 2008 May 15; 197 Suppl 3():S261-71. PubMed ID: 18447612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.